Highly Effective Against News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from CureVac, CureVac and GSK's Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study

Issuer: CureVac / Key word(s): Study21.04.2022 / 13:00 The issuer is solely responsible for the content of this announcement.CureVac and GSK's Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study- Vaccine candidate combining Beta- and Delta-...